Your search returned 3 results.

Results
	1.	Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion-With an application to the design of a clinical trial in acute myeloid leukemia. [electronic resource] by Rufibach, Kaspar Heinzmann, Dominik Monnet, Annabelle Producer: 20201211 In: Pharmaceutical statistics vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia. [electronic resource] by Montesinos, Pau Beckermann, Benjamin M Catalani, Olivier Esteve, Jordi Gamel, Katia Konopleva, Marina Y Martinelli, Giovanni Monnet, Annabelle Papayannidis, Cristina Park, Aaron Récher, Christian Rodríguez-Veiga, Rebeca Röllig, Christoph Vey, Norbert Wei, Andrew H Yoon, Sung-Soo Fenaux, Pierre Producer: 20210127 In: Future oncology (London, England) vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study. [electronic resource] by Ou, Sai-Hong Ignatius Ahn, Jin Seok De Petris, Luigi Govindan, Ramaswamy Yang, James Chih-Hsin Hughes, Brett Lena, Hervé Moro-Sibilot, Denis Bearz, Alessandra Ramirez, Santiago Viteri Mekhail, Tarek Spira, Alexander Bordogna, Walter Balas, Bogdana Morcos, Peter N Monnet, Annabelle Zeaiter, Ali Kim, Dong-Wan Producer: 20160629 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)